Companies: 10,795·Total market cap: $144.5T
HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS.TOTSXHealthcare● Active
$4.41
$-0.06(-1.34%)
Market Cap$137917017
P/E Ratio
52W High$5.765
52W Low$0.001
Overview

HLS Therapeutics Inc.(HLS.TO)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HLS.TO · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$11.70M$17.46M$21.95M$20.72M$21.18M
Net Receivables$7.85M$7.53M$10.69M$11.19M$11.51M
Inventory$8.12M$9.06M$9.53M$8.90M$8.93M
Total Current Assets$29.04M$35.40M$44.09M$44.37M$43.75M
PP&E Net$1.34M$1.00M$0.96M$1.13M$1.57M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$105.43M$122.12M$162.34M$195.02M$229.18M
Total Assets$137.28M$159.90M$209.06M$241.65M$275.90M
Liabilities
Short-Term Debt$4.81M$4.83M$4.69M$13.06M$12.00M
Accounts Payable$10.42M$8.71M$14.11M$11.59M$9.32M
Total Current Liabilities$26.07M$22.55M$26.69M$31.19M$27.67M
Long-Term Debt$44.37M$60.74M$82.05M$83.28M$84.13M
Total Liabilities$75.72M$88.56M$111.36M$116.33M$115.17M
Stockholders Equity
Retained Earnings($203.78M)($194.18M)($175.46M)($148.45M)($119.86M)
Total Stockholders Equity$61.56M$71.34M$97.70M$125.32M$160.74M
Total Liab & Equity(computed)$137.28M$159.90M$209.06M$241.65M$275.90M
Debt Summary
Total Debt$49.73M$66.45M$87.62M$97.34M$97.57M
Net Debt$38.03M$48.99M$65.67M$76.62M$76.39M

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解HLS Therapeutics Inc.

关于HLS Therapeutics Inc.(HLS.TO)资产负债表

HLS Therapeutics Inc.总资产$0.14B,现金及短期投资$0.01B,总负债$0.08B,总债务$0.05B,股东权益$0.06B。

常见问题

HLS.TO · 4 问

HLS Therapeutics Inc.总债务$0.05B,净债务$0.04B。

HLS.TO total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10